11 results
·
26ms
·
Sources: EU EUDAMED, US FDA
Filters
Regulation: Us FDA
×
CERAMIC SPHERICAL CMC IMPLANT (SUBJECT TO MARKETING APPROVAL)
FDA 510(k)
FDA Class 2
·Orthopedic
CALCIPULPE
FDA 510(k)
FDA Class 2
·Dental
ASAHI CHIKAI Neurovascular Guide Wire (Round Curve)
FDA 510(k)
FDA Class 2
·Cardiovascular
HEARTSTART ONSITE
FDA Adverse Event
Malfunction
·PHILIPS MEDICAL SYSTEMS·Product code MKJ·June 9, 2014
9800
FDA Adverse Event
Malfunction
·GE OEC MEDICAL SYSTEMS (SLC)·Product code JAA·January 25, 2013
PRECISION XTRA
FDA Adverse Event
Malfunction
·Product code NBW·January 13, 2011
NASAL-AIRE
FDA Adverse Event
Malfunction
·INNOMED TECHNOLOGIES·Product code BYE·January 6, 2003
MONOCRYL UD 27IN USP2-0
FDA Adverse Event
Malfunction
·ETHICON INC.·Product code GAN·October 25, 2024
MONOCRYL UD 27IN USP2-0
FDA Adverse Event
Malfunction
·ETHICON INC.·Product code GAN·October 25, 2024
CPT Hip System, Parts 00-8114-002-10 and 00-8011-004-00 Hip joint metal/polymer semi-constrained cemented prosthesis. The CPT Hip System is indicated for cemented use in: Patients suffering from severe hip pain and disability due to rheumatoid arthritis, osteoarthritis, traumatic arthritis, polyarthritis, collagen disorders, avascular necrosis of the femoral head, and nonunion of previous fractures of the femur. Patients with congenital hip dysplasia, protrusio acetabuli, or slipped capital femoral epiphysis. Patients suffering from disability due to previous fusion. Patients with previously failed endoprostheses and/or total hip components in the affected extremity. Patients with acute femoral neck fractures. 510(k) K960658
FDA Enforcement
Class II
·Terminated·Zimmer, Inc.·January 8, 2014
CPT Hip System, Parts 00-8114-002-10 and 00-8011-004-00 Hip joint metal/polymer semi-constrained cemented prosthesis. The CPT Hip System is indicated for cemented use in: Patients suffering from severe hip pain and disability due to rheumatoid arthritis, osteoarthritis, traumatic arthritis, polyarthritis, collagen disorders, avascular necrosis of the femoral head, and nonunion of previous fractures of the femur. Patients with congenital hip dysplasia, protrusio acetabuli, or slipped capital femoral epiphysis. Patients suffering from disability due to previous fusion. Patients with previously failed endoprostheses and/or total hip components in the affected extremity. Patients with acute femoral neck fractures. 510(k) K960658
FDA Recall
Terminated
·Zimmer, Inc.·Product code JDI·December 10, 2013